Kevin is the Gertrude Biomedical Scientific Team Leader, who has more than 10 years’ drug discovery experience. Before joining Gertrude Biomedical, Kevin worked at St Vincent’s Institute of Medical Research, developing anti-diabetic therapeutics targeting a metabolic kinase which resulted in being awarded several prizes and fellowships. Kevin has a proven academic track record in drug design and development, and previously collaborated with academia and various pharmaceutical industries. As a protein chemist, he has been involved in developing Gertrude Biomedical’s drug screening pipeline and novel biochemical/biophysical assays in high throughput format. He has a strong passion to translate his scientific knowledge to help improving human health.